Jazz Pharmaceuticals

ASCO: Jazz shares 'unprecedented' HER2 biliary tract cancer data ahead of FDA decision
Fierce Biotech
Sun, 06/2/24 - 02:48 pm
ASCO 2024
Jazz Pharmaceuticals
advanced biliary tract cancer
zanidatamab
Jazz brings the noise to the FDA with lawsuit over approval of Avadel's narcolepsy drug Lumryz
Fierce Pharma
Sun, 06/25/23 - 09:41 pm
Jazz Pharmaceuticals
FDA
legal
Avadel Pharmaceuticals
Lumryz
Xyrem
BIO: Jazz is auditioning new bandmates in an M&A market ripe with talent
Fierce Biotech
Tue, 06/6/23 - 11:16 am
Jazz Pharmaceuticals
Bruce Cozadd
M&A
BIO 2023
neurology
oncology
Jazz wins reimbursement nod from NICE for cannabinoid med Epidyolex
Fierce Pharma
Wed, 02/1/23 - 10:12 pm
Jazz Pharmaceuticals
Epidyolex
UK
NICE
cannabinoids
Competition is on the horizon for costly narcolepsy treatments
Pharmaphorum
Wed, 12/14/22 - 10:26 am
narcolepsy
Jazz Pharmaceuticals
Molina Healthcare
Avadel
Harmony Biosciences
Jazz plays coda to blood cancer approval, securing FDA nod for revised dosing schedule
Fierce Pharma
Tue, 11/22/22 - 04:41 pm
Jazz Pharmaceuticals
FDA
Rylaze
blood cancer
acute lymphoblastic leukemia
lymphoblastic lymphoma
FTC Amicus Brief Challenges Abuse of FDA “Orange Book” Listing Procedures to Block Drug Competition
FTC
Sun, 11/13/22 - 06:56 pm
legal
FTC
Orange Book
Jazz Pharmaceuticals
Avadel Pharma
patents
competition
FDA Keeps Jazz’s SCLC Treatment on the Market Despite Failed Confirmatory Trial
BioSpace
Thu, 10/27/22 - 08:14 pm
Jazz Pharmaceuticals
FDA
Zepzelca
small cell lung cancer
FDA explains why it won't pull Jazz's accelerated approval despite a failed confirmatory trial
Endpoints
Wed, 10/26/22 - 10:34 am
Jazz Pharmaceuticals
FDA
metastatic small cell lung cancer
lung cancer
Zepzelca
Buy now, pay later: Jazz hands over $50M for Zymeworks' phase 3 HER2-directed bispecific
Fierce Biotech
Wed, 10/19/22 - 10:42 am
Jazz Pharmaceuticals
Zymeworks
HER2 inhbitor
bispecific antibodies
Few biopharma risers stand out at the half year
EP Vantage
Wed, 07/13/22 - 10:06 am
Lantheus Medical
Vertex Pharmaceuticals
Jazz Pharmaceuticals
COVID-19
CEL-SCI, Jazz, CARsgen, Ascentage and Portage Showcase New Data at ASCO
BioSpace
Wed, 06/8/22 - 10:37 am
ASCO 2022
oncology
Cel-Sci
Jazz Pharmaceuticals
CARsgen
Ascentage
Portage
Rylaze
Multikine
olverembatinib
CT041
Jazz, Werewolf to howl at the moon together in $1.26B backloaded biobucks pact
Fierce Biotech
Thu, 04/7/22 - 10:28 am
Jazz Pharmaceuticals
Werewolf Therapeutics
biobucks
tumors
WTX-613
Rare disease and neurology take outs tick higher
EP Vantage
Wed, 03/2/22 - 10:03 am
M&A
AbbVie
AstraZeneca
Bristol Myers Squibb
JNJ
Gilead Sciences
Jazz Pharmaceuticals
Merck
Pfizer
Sanofi
rare disease
neurology
In a quiet year for takeouts, who was buying?
EP Vantage
Fri, 01/28/22 - 09:54 am
M&A
Jazz Pharmaceuticals
Horizon Pharma
MorphoSys
Xywav Narcolepsy Drug Scores FDA Approval for Rare Sleep Disorder
Xtalks
Thu, 08/19/21 - 10:52 am
Jazz Pharmaceuticals
Xywav
narcolepsy
FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav
Yahoo/Reuters
Thu, 08/12/21 - 10:54 pm
Jazz Pharmaceuticals
Xywav
FDA
idiopathic hypersomnia
Biotech M&A tracker: After hitting new heights, deals have slowed down. Here are the latest.
BioPharma Dive
Tue, 08/10/21 - 11:12 pm
M&A
Bayer
Sanofi
Amgen
uniQure
MorphoSys
Xeris Pharmaceuticals
Relay Therapeutics
Merck
Beam Therapeutics
Jazz Pharmaceuticals
Jazz Pharma (JAZZ) Gets FDA Approval for Leukemia Drug Rylaze
Yahoo/Zacks.com
Thu, 07/1/21 - 10:33 am
Jazz Pharmaceuticals
FDA
Rylaze
JZP-458
acute lymphoblastic leukemia
lymphoblastic lymphoma
Jazz recognizes less-common small cell lung cancer patients' needs with new online initiative
Fierce Pharma
Mon, 06/21/21 - 10:46 am
Jazz Pharmaceuticals
patient education
small cell lung cancer

Pages